Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
Diabetes. 2005 Oct;54(10):2988-94. doi: 10.2337/diabetes.54.10.2988.
Diabetes. 2005.
PMID: 16186403
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.
Vora KA, Porter G, Peng R, Cui Y, Pryor K, Eiermann G, Zaller DM.
Vora KA, et al. Among authors: pryor k.
BMC Immunol. 2009 Apr 9;10:19. doi: 10.1186/1471-2172-10-19.
BMC Immunol. 2009.
PMID: 19358731
Free PMC article.
Item in Clipboard
A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice.
Berger JP, SinhaRoy R, Pocai A, Kelly TM, Scapin G, Gao YD, Pryor KAD, Wu JK, Eiermann GJ, Xu SS, Zhang X, Tatosian DA, Weber AE, Thornberry NA, Carr RD.
Berger JP, et al. Among authors: pryor kad.
Endocrinol Diabetes Metab. 2017 Nov 24;1(1):e00002. doi: 10.1002/edm2.2. eCollection 2018 Jan.
Endocrinol Diabetes Metab. 2017.
PMID: 30815539
Free PMC article.
Item in Clipboard
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.
Migoya EM, Bergeron R, Miller JL, Snyder RN, Tanen M, Hilliard D, Weiss B, Larson P, Gutierrez M, Jiang G, Liu F, Pryor KA, Yao J, Zhu L, Holst JJ, Deacon C, Herman G, Thornberry N, Amatruda J, Williams-Herman D, Wagner JA, SinhaRoy R.
Migoya EM, et al. Among authors: pryor ka.
Clin Pharmacol Ther. 2010 Dec;88(6):801-8. doi: 10.1038/clpt.2010.184. Epub 2010 Nov 3.
Clin Pharmacol Ther. 2010.
PMID: 21048706
Clinical Trial.
Item in Clipboard
Crystallization and preliminary X-ray analysis of the Escherichia coli UDP-MurNAc-tripeptide D-alanyl-D-alanine-adding enzyme (MurF).
Yan Y, Munshi S, Li Y, Pryor KA, Marsilio F, Leiting B.
Yan Y, et al. Among authors: pryor ka.
Acta Crystallogr D Biol Crystallogr. 1999 Dec;55(Pt 12):2033-4. doi: 10.1107/s0907444999011786.
Acta Crystallogr D Biol Crystallogr. 1999.
PMID: 10666581
Item in Clipboard
Cite
Cite